FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to phthisiology, and concerns increasing the effectiveness of anti-tuberculosis therapy. For this, from the first day until the end of the main course of anti-tuberculosis chemotherapy, 10 ml of licorice root syrup is additionally administered orally, 10 ml three times a day before meals, and the drug "Phosphogliv" is administered during the intensive phase of the main course of anti-tuberculosis therapy intravenously, 5 g three times a week, and on the remaining days of the week, orally, 2 capsules 3 times a day; during the phase of continued therapy of the main course, the drug "Phosphogliv" is administered orally 2 capsules 3 times a day.
EFFECT: invention provides a decrease in bacillus excretion, closure of decay cavities, a decrease in the severity of undesirable side effects of anti-tuberculosis drugs due to the immunomodulatory, membrane-stabilizing, hepatoprotective, expectorant and anti-inflammatory effects of the administered drugs.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING PATIENTS FOR PULMONARY TUBERCULOSIS | 2007 |
|
RU2318515C1 |
METHOD OF TREATING PATIENTS WITH DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS | 2015 |
|
RU2587332C1 |
METHOD OF TREATING PULMONARY TUBERCULOSIS IN HIV-PATIENTS | 2008 |
|
RU2380114C1 |
METHOD FOR TREATMENT OF PATIENTS WITH PULMONARY TUBERCULOSIS | 2015 |
|
RU2611391C1 |
METHOD OF TREATMENT OF PULMONARY TUBERCULOSIS | 2007 |
|
RU2323739C1 |
METHOD OF PATHOGENETIC TREATMENT OF PATIENTS SUFFERING FROM INFILTRATIVE PULMONARY TUBERCULOSIS | 1992 |
|
RU2050855C1 |
METHOD FOR TREATING PULMONARY TUBERCULOSIS | 2006 |
|
RU2302251C1 |
METHOD FOR TREATING PULMONARY TUBERCULOSIS | 2004 |
|
RU2253460C1 |
METHOD OF PULMONARY TUBERCULOSIS TREATMENT | 2006 |
|
RU2329803C1 |
METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS WITH ACCOMPANYING NON-SPECIFIC BRONCHITES | 2013 |
|
RU2526121C1 |
Authors
Dates
2021-07-19—Published
2020-12-25—Filed